Plasma Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-2028]

Plasma Fractionation Market: Trends, Opportunities and Competitive Analysis [2023-2028]

Plasma Fractionation Market Trends and Forecast

The future of the plasma fractionation market looks promising with opportunities in hospitals & clinics and clinical research. The global plasma fractionation market is expected treach an estimated $42.7 billion by 2028 with a CAGR of 7% from 2023 t2028. The major drivers for this market are rising geriatric population, increasing prevalence of respiratory diseases, and growing use of immunoglobulin in different therapeutic applications.

Plasma Fractionation Market by Product, Method, Application, End Use Industry, and Region

A more than 150-page report is developed thelp in your business decisions. A sample figure with some insights is shown below.

Plasma Fractionation Market by Segments

Plasma Fractionation Market by Segment

The study includes trends and forecast for the global plasma fractionation market by product, method, application, end use industry, and region, as follows:

Plasma Fractionation Market by Product [Value ($B) Shipment Analysis from 2017 t2028]:

Albumin

Immunoglobulins

Intravenous immunoglobulins

Subcutaneous immunoglobulins

Others

Coagulation Factors

Factor VIII

Factor IX

Von Willebrand Factor

Prothrombin Complex Concentrates

Fibrinogen Concentrates

Others

Protease Inhibitors

Others

Plasma Fractionation Market by Method [Value ($B) Shipment Analysis from 2017 t2028]:

Centrifugation

Depth Filtration

Chromatography

Others

Plasma Fractionation Market by Application [Value ($B) Shipment Analysis from 2017 t2028]:

Neurology

Hematology

Oncology

Immunology

Pulmonology

Others

Plasma Fractionation Market by End Use Industry [Value ($B) Shipment Analysis from 2017 t2028]:

Hospitals & Clinics

Clinical Research

Others

Plasma Fractionation Market by Region [Value ($B) Shipment Analysis from 2017 t2028]:

North America

Europe

Asia Pacific

The Rest of the World

List of Plasma Fractionation Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, plasma fractionation companies cater tincreasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the plasma fractionation companies profiled in this report include-

Grifols

CSL

Takeda Pharmaceutical

Octapharma

Kedrion

Plasma Fractionation Market Insights

Lucintel forecasts that immunoglobulin will remain the largest product segment over the forecast period due tthe increasing prevalence of infections and disorders and its extensive use in treatment, diagnosis, and administration of metabolic diseases.

Hospitals & clinics are expected tremain the largest end use industry segment due tthe extensive use of plasma fractionation among hospitals and clinics ttreat various diseases.

North America will remain the largest region due tan increase in the quantity of plasma collection facilities, rise in the demand for immunoglobulin, and growing number of elderly people with hereditary diseases in the region.

Features of the Plasma Fractionation Market

Market Size Estimates: Plasma fractionation market size estimation in terms of value ($B)

Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.

Segmentation Analysis: Plasma fractionation market size by various segments, such as product, method, application, end use industry, and region

Regional Analysis: Plasma fractionation market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.

Growth Opportunities: Analysis on growth opportunities in different products, methods, applications, end use industries, and regions for the plasma fractionation market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape for the plasma fractionation market.

Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the plasma fractionation market size?

Answer: The global plasma fractionation market is expected treach an estimated $42.7 billion by 2028.

Q2. What is the growth forecast for plasma fractionation market?

Answer: The global plasma fractionation market is expected tgrow with a CAGR of 7% from 2023 t2028.

Q3. What are the major drivers influencing the growth of the plasma fractionation market?

Answer: The major drivers for this market are rising geriatric population, increasing prevalence of respiratory diseases, and growing use of immunoglobulin in different therapeutic applications.

Q4. What are the major segments for plasma fractionation market?

Answer: The future of the plasma fractionation market looks promising with opportunities in hospitals & clinics and clinical research.

Q5. Whare the key plasma fractionation companies?

Answer: Some of the key plasma fractionation companies are as follows:

Grifols

CSL

Takeda Pharmaceutical

Octapharma

Kedrion

Q6. Which plasma fractionation segment will be the largest in the future?

Answer: Lucintel forecasts that immunoglobulin will remain the largest product segment over the forecast period due tthe increasing prevalence of infections and disorders and its extensive use for the treatment, diagnosis, and administration of metabolic diseases.

Q7. In plasma fractionation market, which region is expected tbe the largest in next 5 years?

Answer: North America will remain the largest region due tincrease in quantity of plasma collection facilities, rise in the demand for immunoglobulin, and growing number of elderly people with hereditary diseases in the region.

Q8. Dwe receive customization in this report?

Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q.1. What are some of the most promising, high-growth opportunities for the plasma fractionation market by product (albumin, immunoglobulins, coagulation factors, protease inhibitors, and others), method (centrifugation, depth filtration, chromatography, and others), application (neurology, hematology, oncology, immunology, pulmonology, and others), end use industry (hospitals & clinics, clinical research, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Whare the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat dthey pose for loss of market share by material or product substitution?

Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

For any questions related tplasma fractionation market or related tplasma fractionation companies, plasma fractionation market size, plasma fractionation market share, plasma fractionation analysis, write Lucintel analyst at email: [email protected] we will be glad tget back tyou soon.
Please note: it takes 3-4 weeks’ time for reports to be delivered after receiving the order confirmation.